Childhood Kidney Diseases

Korean Society of Pediatric Nephrology (대한소아신장학회)
권호 표지
DOI QR코드

DOI QR Code

Hypokalemia-induced Polyuria with Nocturia after Intravenous Methylprednisolone Pulse Therapy in a Henoch-Sch$\ddot{o}$nlein Purpura Nephritis Patient

Henoch-Sch$\ddot{o}$nlein Purpura 신염 환자에서 경정맥 고용량 스테로이드 충격요법 후 발생된 저칼륨혈증으로 인한 다뇨증과 야간뇨

  • Kim, Geun-Jung (Department of Pediatrics, CHA University, CHA Bundang Medical Center) ;
  • Lee, Jun-Ho (Department of Pediatrics, CHA University, CHA Bundang Medical Center)
  • 김근정 (차의과대학교 분당차병원 소아청소년과) ;
  • 이준호 (차의과대학교 분당차병원 소아청소년과)
  • Received : 2010.08.06
  • Accepted : 2010.09.03
  • Published : 2010.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Patients with moderate to severe degrees of Henoch-Sch$\ddot{o}$nlein purpura (HSP) nephritis receive high-dose intravenous methylprednisolone pulse therapy (IMPT). Although the regimen is generally safe and effective, various complications occasionally develop. administration of excessive corticosteroid can induce urinary potassium wasting leading to hypokalemia. Polyuria, one of the complications of hypokalemia, is related to both increased thirst and mild nephrogenic diabetes insipidus. And hypokalemia itself also impairs the maximal renal urinary concentration ability. Although polyuria or nocturia after IMPT is not common, it is correctable immediately by oral potassium supplementation. Therefore, during IMPT, careful history taking of nocturia as well as monitoring urine volume, serum and urine potassium level at regular follow-up are necessary because even mild hypokalemia can provoke urine concentrating ability defect. We experienced a case of 11 year-old boy with HSP nephritis who suffered from hypokalemia-induced polyuria with nocturia right after IMPT.

경정맥 고용량 스테로이드 충격요법(IMPT)의 부작용으로는 고혈압, 동성 서맥, 심방심실 전도장애, 심방 세동, 심방 조동, 심실 빈맥 등의 부정맥, 구토, 구역질 등의 소화기 장애, 백내장, 저칼륨혈증, 그리고 감염성 질환 등이 있다. 그중, 저칼륨혈증은 IMPT를 받는 환자의 17% 정도에서 경미하게 나타날 수 있다. 저칼륨혈증이 신수질의 요농축 능력을 저하시켜 다뇨가 발생할 수 있다는 사실은 이미 알려져 있지만, IMPT후 경미한 저칼륨혈증으로 인해 심한 야간뇨과 다뇨증이 발생하였다는 보고는 별로 없다. 이에 본 저자들은 다량의 단백뇨와 혈뇨를 보이는 HSP 신염환자에게 세 차례의 IMPT 시행 후 환아에게 발생한 경미한 저칼륨혈증으로 인한 심한 야간뇨와 다뇨증의 발생을 경험하였기에 이에 보고하는 바이다.

Keywords

References

  1. Joseph TF, Willam ES, Timothy EB, David BK, Aileen BS. Treatment of Henoch- Schonlein purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide. Am J Nephrol 2001;21: 128-33. https://doi.org/10.1159/000046235
  2. Jonathan DA, Brian MF, Gil JG, Gross ED. Sinus bradycardia after intravenous methylpredisolone. Pediatrics 2007;119:e778-82. https://doi.org/10.1542/peds.2006-0029
  3. Abraham C, Richard T, Richard D. Prednisolone in the treatment of rheumatoid arthritis. N Engl J Med 1955;253:1150-2. https://doi.org/10.1056/NEJM195512292532604
  4. Andreas HB. Steroid-resistant kidney transplant rejection: Diagnosis and treatment. J Am Soc Nephrol 2001;12:48-52.
  5. Pankaj H, Rajendra NS. Pulse corticosteroid therapy with methylprednisolone or dexamethsone. Indian journal of pediatrics 1998; 65:557-60. https://doi.org/10.1007/BF02730894
  6. Patric N, Renee H. Methylprednisolone pulse therapy in the treatment of severe forms Schonlein-Henoch purpura nephritis. Pediatr Nephrol 1998;12:238-43. https://doi.org/10.1007/s004670050446
  7. Bonnotte B, Chauffert B, Martin F, Lorcerie B. Side-effects of high-dose intravenous (pulse) methylprednisolone therapy cured by potassium infusion. Br J Rheumatol 1998; 37(suppl 1):109.
  8. Mujais SK, Katz AI. Potassium deficiency. In : Seldin DW, Giebisch G, editors. The kidney: Physiology and Pathophysiology. New York : Raven Press Ltd, 1992:2249-78.
  9. Squires RD, Huth EJ. Experimental potassium depletion in normal human subjects. I. Relation of ionic intakes to the renal conservation of potassium. J Clin Invest 1959;38: 1134-48. https://doi.org/10.1172/JCI103890
  10. Young DB. Quantitative analysis of aldosterone's role in potassium regulation. AM J Physiol 1988;255:811-22.
  11. URL://http://www.uptodate.com/home/index. html
  12. Jones DP, Chesney RW. Renal toxicity of cancer chemotherapeutic agents in children: ifosfamide and cisplatin. Curr Opin Pediatr 1995;7:208-13. https://doi.org/10.1097/00008480-199504000-00016
  13. Tamez-Perez HE, Cisneros-Perez V, Cedillo- Rodriguez JA, Diaz-De-Leon-Gonalez E, Torres-Valenzueia M, Tamez-Pena AL et al. Prevalence of hypokalemia in patients with methylprednisolone pulse therapy. Rev Invest Clin 2009;61:194-7.
  14. Kim JK, Summer SN, Berl T. The cyclic AMP system in the inner medullary collecting duct of the potassium-depleted rat. Kidney Int 1984;26:384-91. https://doi.org/10.1038/ki.1984.186
  15. Galvez OG, Bay WH, Roberts BW, Ferris TF. The hemodynamic effect of potassium d-eficiency in the dog. Circ Res 1977;40 (suppl 1):11-6.
  16. Terris J, Ecelbarger CA, Marples D, Knepper MA, Nielsen S. Distribution of aquaporin- 4 water channel expression withing rat kidney. Am J Physiol Renal Physiol 1995; 269:F775-85. https://doi.org/10.1152/ajprenal.1995.269.6.F775
  17. Rutecki GW, Cox JW, Robertson GW, Francisco LL, Ferris TF. Urinary concentrating ability and antidiuretic hormone responsiveness in the potassium-depleted dog. J Lab Clin Med 1982;100:53-60.
  18. Kannegiesser H, Lee JB. Role of outer medullary metabolism in the concentrating defect of K+ depletion. Am J Physiol 1971; 220:1701-7.
  19. Manitius A, Levitin H, Beck D, Epstein FH. On the mechanism of impairment of renal concentrating ability in potassium defiency. J Clin Invest 1960;39:684-94. https://doi.org/10.1172/JCI104084
  20. Gennari FJ. Hypokalemia. N Engl J Med 1998;339:451-8. https://doi.org/10.1056/NEJM199808133390707